2-溴-N-[4-氯-3-[[(3R)-1-甲基-3-吡咯烷基]氧基]苯基]-4,5-二甲氧基-苯磺酰胺
![2-溴-N-[4-氯-3-[[(3R)-1-甲基-3-吡咯烷基]氧基]苯基]-4,5-二甲氧基-苯磺酰胺结构式](https://image.chemsrc.com/caspic/148/474960-44-6.png)
2-溴-N-[4-氯-3-[[(3R)-1-甲基-3-吡咯烷基]氧基]苯基]-4,5-二甲氧基-苯磺酰胺结构式
|
常用名 | 2-溴-N-[4-氯-3-[[(3R)-1-甲基-3-吡咯烷基]氧基]苯基]-4,5-二甲氧基-苯磺酰胺 | 英文名 | SB 657510 |
|---|---|---|---|---|
| CAS号 | 474960-44-6 | 分子量 | 505.81000 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C19H22BrClN2O5S | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS07 |
信号词 | Warning |
|
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.
Diabetologia 56(5) , 1155-65, (2013) The small, highly conserved vasoactive peptide urotensin II (UII) is upregulated in atherosclerosis. However, its effects in diabetes-associated atherosclerosis have not been assessed.Endothelial cells were grown in normal- and high-glucose (5 and 25 mmol/l) ... |
期刊文献综述：
更多...